Who
Johanne Kaplan
Chief Development Officer
Company insider
Files Form 4 as: Chief Development Officer, ProMIS Neurosciences.
In numbers
- Trades disclosed
- 13
- Buys
- 2
- Sells
- 0
- Bought
- $111K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Oct 2023
- Last trade
- 5 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 7 Aug 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $30K2,280 at $13.30 | filing |
| 5 Aug 2026filed 7 Aug 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $30K2,280 at $13.30 | filing |
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $25K1,629 at $15.35 | filing |
| 19 Feb 2026filed 23 Feb 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $25K1,629 at $15.35 | filing |
| 3 Feb 2026filed 5 Feb 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Code A | $25K2,060 at $12.13 | filing |
| 3 Feb 2026filed 5 Feb 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,060 | filing |
| 3 Feb 2026filed 5 Feb 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,060 | filing |
| 3 Feb 2026filed 5 Feb 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Code A | $25K2,060 at $12.13 | filing |
| 22 Sep 2025filed 24 Sep 2025 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 18 Nov 2024filed 20 Nov 2024 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 26 Oct 2023filed 30 Oct 2023 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.